Scam, kidnap by South African police

Scam, kidnap by South African police

Medical Writing Institute click here

MJoTAtalks click here

Emerald Pademelon Press LLC click here


Peace Scientists click here

Dr Susanna loves the countries and the peoples of Africa

Scam, kidnap by South African police

Scam, kidnap by South African police

 
Bookmark and Share
Don't get diabetes! Take care of yourself if you have it! Diabetes resources, click here.
Diabetes News
Clinical trials testing therapies for diabetes

Latest Top (15) News


A Non-interventional Study of Ability and Willingness to Pay for BIAsp 30 in a Real World Population With Type 2 Diabetes Mellitus (T2DM)
Conditions:   Diabetes;   Diabetes Mellitus, Type 2
Intervention:   Other: BIAsp 30
Sponsor:   Novo Nordisk A/S
Enrolling by invitation

Fri, 15 Dec 2017 12:00:00 EST


Efficacy of Amoxicillin-metronidazole Compared to Clindamycin in Patients With Periodontitis and Diabetes
Conditions:   Periodontitis;   Periodontal Pocket;   Diabetes Mellitus
Interventions:   Drug: Amoxicillin 500 mg / Metronidazole 250 mg;   Drug: Clindamycin 300 mg
Sponsor:   Centro Universitario de Tonalá
Completed

Fri, 15 Dec 2017 12:00:00 EST


Pilot of Home Visitation Services for Patients With a Diabetes Diagnosis
Condition:   Diabetes
Interventions:   Behavioral: Home Visitiation;   Behavioral: Education
Sponsors:   Delta Health Alliance;   University of Tennessee Health Science Center
Not yet recruiting

Fri, 15 Dec 2017 12:00:00 EST


Type 1 Diabetes Telemedicine
Condition:   Diabetes Mellitus, Type 1
Intervention:   Behavioral: Telemedicine Intervention
Sponsor:   University of California, Davis
Recruiting

Fri, 15 Dec 2017 12:00:00 EST


Early Diagnosis of TTR Amyloidosis by Use of Molecular Biology
Condition:   Polyneuropathy, Diagnosis, Molecular Gene Testing, Idiopathic Progressive Polyneuropathy, Early Diagnosis
Intervention:  
Sponsor:   Assistance Publique - Hôpitaux de Paris
Recruiting

Thu, 14 Dec 2017 12:00:00 EST


Glycated Albumin in Pregnancy
Condition:   Gestational Diabetes
Intervention:  
Sponsor:   Helse Stavanger HF
Recruiting

Thu, 14 Dec 2017 12:00:00 EST


Retinal Imaging Using NOTAL-OCT
Conditions:   Age-Related Macular Degeneration;   Diabetic Retinopathy
Intervention:   Device: Notal OCT
Sponsor:   Notal Vision Ltd
Not yet recruiting

Thu, 14 Dec 2017 12:00:00 EST


Analysis of Changes in Medication Prescriptions After Hospitalization for 4 Disciplines: Gerontology, Diabetology, Cardiology and Rheumatology: Medical, Pharmaceutical and Economic Aspects
Conditions:   Diabetes;   Cardiac Disease;   Rheumatic Diseases
Intervention:   Other: collection of prescription data
Sponsor:   Assistance Publique Hopitaux De Marseille
Active, not recruiting

Wed, 13 Dec 2017 12:00:00 EST


Clinical Study to Evaluate Efficacy and Safety of ALLO-ASC-DFU in Patients With Diabetic Foot Ulcers.
Condition:   Diabetic Foot Ulcer
Interventions:   Biological: ALLO-ASC-DFU;   Procedure: Vehicle sheet
Sponsor:   Anterogen Co., Ltd.
Not yet recruiting

Wed, 13 Dec 2017 12:00:00 EST


Gan & Lee Insulin Glargine Target Type (1) Evaluating Research
Condition:   Diabetes Mellitus, Type 1
Interventions:   Biological: Gan & Lee Pharmaceuticals Insulin Glargine;   Biological: Lantus®
Sponsor:   Gan and Lee Pharmaceuticals, USA
Recruiting

Wed, 13 Dec 2017 12:00:00 EST


Gan & Lee Insulin Glargine Target Type (2) Evaluation Research
Condition:   Diabetes Mellitus, Type 2
Interventions:   Biological: Gan & Lee Pharmaceuticals Insulin Glargine;   Biological: Lantus®
Sponsor:   Gan and Lee Pharmaceuticals, USA
Recruiting

Wed, 13 Dec 2017 12:00:00 EST


Healthfulness of Food From Grocery Stores Versus Eating Out Among People Receiving Food Benefits (SNAP)
Condition:   Diet Habit
Intervention:  
Sponsors:   University of North Carolina, Chapel Hill;   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK);   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Completed

Wed, 13 Dec 2017 12:00:00 EST


Intratympanic Stereoidal Injections for Facial Nerve Palsy
Condition:   Bell Palsy
Intervention:   Drug: Dexamethasone
Sponsor:   Hillel Yaffe Medical Center
Not yet recruiting

Wed, 13 Dec 2017 12:00:00 EST


Program ACTIVE II: Behavioral Depression Treatment for Type 2 Diabetes
Conditions:   Type2 Diabetes;   Depression
Interventions:   Behavioral: Program ACTIVE Exercise;   Behavioral: Program ACTIVE CBT;   Behavioral: Program ACTIVE;   Behavioral: Usual Care - No intervention
Sponsors:   Indiana University;   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK);   West Virginia University;   Ohio University;   University of Michigan
Completed

Wed, 13 Dec 2017 12:00:00 EST


Promotora-Led Intervention for Metabolic and Mental Health
Conditions:   PreDiabetes;   Obesity;   Metabolic Disease;   Body Weight Changes;   Diabetes Mellitus
Interventions:   Behavioral: Promotora-led Intervention (PLI);   Behavioral: Usual care (UC)
Sponsors:   Northwestern University;   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Not yet recruiting

Wed, 13 Dec 2017 12:00:00 EST
FDA (Food and Drug Administration) press releases. FDA makes sure of the safety of all medicines which can be injected, breathed in, rubbed in and swallowed, in the United States of America.

Latest Top (10) News


Statement from FDA Commissioner Scott Gottlieb, M.D., on new FDA efforts to support more efficient development of targeted therapies
FDA issues two draft guidances that will provide medical product developers with greater clarity on the FDA’s recommendations for researching and developing the next generation of individualized therapies.

Fri, 15 Dec 2017 10:28:00 -0500


FDA launches new tool for sharing information that allows doctors to better manage antibiotic use; improve patient care
Today the FDA is announcing a new approach to get critical updates regarding antibiotics and antifungal drugs to health care professionals as part of an overall effort to combat antimicrobial resistance. The agency created a website that will provide direct and timely access to information about when bacterial or fungal infections are likely to respond to a specific drug.

Wed, 13 Dec 2017 10:13:00 -0500


FDA approves first drug for Eosinophilic Granulomatosis with Polyangiitis, a rare disease formerly known as the Churg-Strauss Syndrome
FDA approves first drug for a rare autoimmune disease that causes an inflammation in the wall of blood vessels of the body. This is a new indication for a previously-approved drug.

Tue, 12 Dec 2017 10:34:00 -0500


FDA warns companies for promoting alternatives to street drugs
The FDA today posted a warning letter to the marketers and distributors of Legal Lean Syrup, a drink, and Coco Loko, a “snortable” chocolate powder, for selling unapproved new drugs and misbranded drugs.

Tue, 12 Dec 2017 10:03:00 -0500


FDA approves Admelog, the first short-acting "follow-on" insulin product to treat diabetes
The FDA today approved Admelog (insulin lispro injection), a short-acting insulin indicated to improve control in blood sugar levels in adults and pediatric patients 3 years and older with type 1 diabetes mellitus and adults with type 2 diabetes mellitus. Admelog is the first short-acting insulin approved as a “follow-on” product.

Mon, 11 Dec 2017 13:07:00 -0500


FDA launches public education campaign to encourage adult smokers trying to quit cigarettes
Today, the U.S. Food and Drug Administration announced an adult smoking cessation education campaign aimed at encouraging cigarette smokers to quit through messages of support that underscore the health benefits of quitting. These messages will be displayed in and around gas stations and convenience stores – retail locations where smokers face a multitude of triggers and that typically feature cigarette advertisements. The “Every Try Counts” campaign targets smokers ages 25-54 who have attempted to quit smoking in the last year but were unsuccessful. The two-year campaign launches next month in 35 U.S. markets and features print, digital, radio, and out-of-home ads, such as on billboards.

Mon, 11 Dec 2017 09:14:00 -0500


Remarks from FDA Commissioner Scott Gottlieb, M.D., as prepared for oral testimony before the U.S. Senate Committee on Health, Education, Labor & Pensions Hearing, “Implementation of the 21st Century Cures Act: Progress and the Path Forward for Medical Innovation
FDA Commissioner Gottlieb testifies before the U.S. Senate Committee on Health, Education, Labor & Pensions on the agency’s implementation of the 21st Century Cures Act

Thu, 07 Dec 2017 10:48:00 -0500


Statement from FDA Commissioner Scott Gottlieb, M.D., on advancing new digital health policies to encourage innovation, bring efficiency and modernization to regulation
Statement from FDA Commissioner Scott Gottlieb, M.D., on advancing new digital health policies to encourage innovation, bring efficiency and modernization to regulation

Thu, 07 Dec 2017 09:00:00 -0500


Statement by FDA Commissioner Scott Gottlieb, M.D., on FDA ushering in new era of 3D printing of medical products; provides guidance to manufacturers of medical devices
The FDA is issuing final guidance on the technical considerations for the 3D printing of medical devices. The recommendations clarify what the FDA recommends manufacturers include in submissions for 3D printed medical products.

Mon, 04 Dec 2017 11:10:00 -0500


FDA approves first biosimilar for the treatment of certain breast and stomach cancers
FDA approves first biosimilar for the treatment of certain breast and stomach cancers

Fri, 01 Dec 2017 10:39:00 -0500
Diabetes news from the American Diabetes Association

Latest Top (5) News